Related Experiment Video
Updated: Sep 15, 2025
07:42
An Automated T-maze Based Apparatus and Protocol for Analyzing Delay- and Effort-based Decision Making in Free Moving Rodents
Published on: August 2, 2018
13.8K
Cholinergic modulation of dopamine release drives effortful behavior
Gavin C Touponse1,2, Matthew B Pomrenze3,2, Teema Yassine1
1Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305.
Biorxiv : the Preprint Server for Biology
|July 16, 2025
Summary
Effort amplifies dopamine release, driven by acetylcholine acting on dopamine axons in the nucleus accumbens. This mechanism enhances motivation for rewards, even in challenging conditions.
Area of Science:
- Neuroscience
- Behavioral Science
Background:
- Individuals often prefer rewards that require greater effort.
- The neural basis for this effort-driven reward enhancement is not well understood.
Purpose of the Study:
- To investigate the neural mechanisms underlying the amplification of reward value by effort.
Main Methods:
- Examined dopamine and acetylcholine interactions in the nucleus accumbens during effortful reward-seeking tasks.
- Utilized techniques to measure neurotransmitter release and block specific receptor actions.
Main Results:
- Effortful tasks increase dopamine release in response to rewards.
- Acetylcholine release in the nucleus accumbens modulates dopamine axon terminals, amplifying dopamine release.
- Blocking this cholinergic modulation impairs effortful behavior.
Conclusions:
- A novel mechanism involving acetylcholine-dopamine interactions in the nucleus accumbens drives effortful behavior.
- This pathway enhances reward motivation, particularly in high-effort contexts.
Related Concept Videos
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
843
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
843
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.3K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.3K
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.6K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.6K
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.4K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.4K
01:23Cholinergic Neurons: Neurotransmission
3.8K
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
3.8K